KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2

Lan Suna Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Xiaona Zhoub Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Yanmeng Lic Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China;d National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Wei Chenc Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Shanna Wue Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Bei Zhangc Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China;d National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Jingyi Yaoc Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information

Anjian Xuc Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China;d National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-4186-9485 View further author information

show all

KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date